Proactive Investors - Run By Investors For Investors

MARKET PREVIEW: FTSE 100 seen higher after Fed comments


Financial bookmakers are expecting UK stocks to open higher after the Federal Reserve indicated no changes to its monetary policy in yesterday’s interest rate announcement. The FTSE 100 is set to open at 5,979, up 23 points (0.4 percent) from Tuesday’s close.

Following Tuesday’s policy meeting, the Federal Reserve said economic conditions in the US were improving and projected further gradual decline in the unemployment rate, which currently stands at three year lows.

The central bank again failed to mention another round of quantitative easing, but restated its intention to keep interest rates at near zero through 2014.

“We now have a clearer understanding of how the Fed is positioned,” said chief market strategist at IG Group Chris Weston.

“Whilst it upgraded certain wording to reflect the economic improvements - suggesting it sees ‘moderate’ rather than ‘modest’ economic growth - it still acknowledged that there are ’strains in the global financial markets’ and it is likely to keep rates low until late 2014.”

Today’s macroeconomic calendar includes US import and export indexes for February and a weekly inventories report from the Department of Energy. 

Across the Atlantic, the Dow Jones Industrial Average (DJIA) rose 218 points (1.7 percent) to end the session at 13,177, the highest level since 2007. The broader S&P 500 index tacked on 25 points (1.8 percent) to close at 1,396.

Stocks in Japan took their cues from US markets with the benchmark Nikkei 225 index rallying 151 points (1.55 percent) reach 10,050. However, China’s Shanghai Composite Index slipped 43 points (1.8 percent) to 2,412.

View full ADM profile View Profile

Archer Daniels Midland Timeline

July 31 2012

Related Articles

cannabis crop
September 17 2018
The cannabis company invests in income-producing property and agricultural equipment to service the blossoming marijuana crop industry
Timber operations
July 10 2018
"Don't get fixated on hurdles in Mozambique," is the message; it's a decreasing part of the business. Far more important is securing the trade finance that would enable the company to scale-up
Originally a research and development company engaged in pioneering research on crop improvement, Arcadia Biosciences is undergoing a transformation, according to CEO Raj Ketkar

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use